These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18516385)

  • 1. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure.
    Cuoco MA; Pereira AC; Mota Gde F; Krieger JE; Mansur AJ
    Arq Bras Cardiol; 2008 Apr; 90(4):252-6. PubMed ID: 18516385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure].
    Huang WY; Sun M; Zhou HY; Pei ZF; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):686-9. PubMed ID: 16114558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure.
    Cicoira M; Rossi A; Bonapace S; Zanolla L; Perrot A; Francis DP; Golia G; Franceschini L; Osterziel KJ; Zardini P
    Am J Med; 2004 May; 116(10):657-61. PubMed ID: 15121491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene polymorphism of angiotensin-converting enzyme and angiotensin II type 1 receptor in patients with congestive heart failure.
    Pop D; Zdrenghea D; Procociuc LM; Popal A
    Rom J Intern Med; 2007; 45(4):349-54. PubMed ID: 18767410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril].
    Tereshchenko SN; Demidova IV; Kobalava ZhD; Moiseev VS
    Ter Arkh; 2002; 74(4):56-8. PubMed ID: 12043242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between ACE gene polymorphism and ischemic chronic heart failure in Turkish population.
    Akbulut T; Bilsel T; Terzi S; Ciloglu F; Unal Dayi S; Sayar N; Peker I; Yesilcimen K
    Eur J Med Res; 2003 Jun; 8(6):247-53. PubMed ID: 12911874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenetics of chronic heart failure--beta blockers].
    Vasků A; Spinarová L; Pávková-Goldbergová M; Spinar J; Soucek M; Vítovec J
    Cas Lek Cesk; 2006; 145(2):148-52; discussion 152-3. PubMed ID: 16521406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
    Rugale C; du Cailar G; Ribstein J; Mimran A
    Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
    Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
    Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction.
    Jeron A; Hengstenberg C; Engel S; Löwel H; Riegger GA; Schunkert H; Holmer S
    Eur Heart J; 2001 Apr; 22(8):663-8. PubMed ID: 11286523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of implantable defibrillator therapy with angiotensin-converting enzyme deletion/insertion polymorphism.
    Bedi MS; Postava LA; Murali S; Macgowan GA; Mathier M; McNamara DM; London B
    J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1162-6. PubMed ID: 15485441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the plasma angiotensin II levels and the risk of chronic heart failure].
    Huang WY; Sun M; Zhou HY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):198-200. PubMed ID: 16145913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between angiotensin-converting enzyme I/D gene polymorphism and pulse pressure in patients with a first anterior acute myocardial infarction.
    Oztürk O; Oztürk U
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):9-14. PubMed ID: 19196567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure.
    de Groote P; Helbecque N; Lamblin N; Hermant X; Amouyel P; Bauters C; Dallongeville J
    Eur J Heart Fail; 2004 Jan; 6(1):17-21. PubMed ID: 15012914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
    Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
    Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure.
    Cuoco MA; Pereira AC; de Freitas HF; de Fátima Alves da Mota G; Fukushima JT; Krieger JE; Mansur AJ
    Int J Cardiol; 2005 Mar; 99(1):97-103. PubMed ID: 15721506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.